Allscripts Healthcare Solutions Inc
NASDAQ:MDRX
Relative Value
The Relative Value of one MDRX stock under the Base Case scenario is 13.45 USD. Compared to the current market price of 7.99 USD, Allscripts Healthcare Solutions Inc is Undervalued by 41%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
MDRX Competitors Multiples
Allscripts Healthcare Solutions Inc Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
US |
Allscripts Healthcare Solutions Inc
NASDAQ:MDRX
|
873.3m USD | 1 | 14.4 | 3.8 | 8.6 | ||
US |
Veeva Systems Inc
NYSE:VEEV
|
32B USD | 13.5 | 60.9 | 60.6 | 65.2 | ||
US |
Cerner Corp
NASDAQ:CERN
|
27.9B USD | 4.8 | 47.3 | 19.6 | 38.6 | ||
US |
Change Healthcare Inc
NASDAQ:CHNG
|
9B USD | 2.6 | -116.8 | 16.5 | 111.6 | ||
AU |
Pro Medicus Ltd
ASX:PME
|
11.6B AUD | 79.6 | 166.9 | 114.8 | 114.8 | ||
JP |
M3 Inc
TSE:2413
|
1.1T JPY | 4.9 | 24.8 | 12.9 | 14.6 | ||
US |
Inspire Medical Systems Inc
NYSE:INSP
|
7.1B USD | 11.4 | -337.7 | -178.6 | -166 | ||
US |
Doximity Inc
NYSE:DOCS
|
4.5B USD | 9.7 | 32.9 | 22 | 23.4 | ||
SE |
Sectra AB
STO:SECT B
|
42.2B SEK | 25.8 | 99.5 | -65.5 | -65.5 | ||
US |
Evolent Health Inc
NYSE:EVH
|
3.2B USD | 1.6 | -22.2 | 26.2 | 278.5 | ||
US |
Goodrx Holdings Inc
NASDAQ:GDRX
|
2.8B USD | 3.7 | -315.5 | 33.6 | -109.9 |